close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

SAN

80.38

-0.73%↓

SAN

80.38

-0.73%↓

SAN

80.38

-0.73%↓

SAN

80.38

-0.73%↓

SAN

80.38

-0.73%↓

Kodu・Aktsiate loetelu・Nanobiotix
Search

Nanobiotix

Suletud

17.74 -1.33

Osta

Hinna uuendus 6. veebr 2026, 16:29 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.74

Max

17.96

Põhinäitajad

By Trading Economics

Sissetulek

-5.4M

Müük

27M

Kasumimarginaal

-20.208

Töötajad

103

EBITDA

1.1M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+26.79% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

1. apr 2026

Turustatistika

By TradingEconomics

Turukapital

860M

Eelmine avamishind

19.07

Eelmine sulgemishind

17.74

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. veebr 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

7. veebr 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

7. veebr 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

7. veebr 2026, 02:46 UTC

Omandamised, ülevõtmised, äriostud

Big Money, High Anxiety -- Barrons.com

DJ

Loe

6. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

6. veebr 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

6. veebr 2026, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

DJ

Loe

6. veebr 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

DJ

Loe

6. veebr 2026, 21:17 UTC

Tulu

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Loe

6. veebr 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

6. veebr 2026, 21:14 UTC

Omandamised, ülevõtmised, äriostud

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

DJ

Loe

6. veebr 2026, 21:13 UTC

Tulu

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

DJ

Loe

6. veebr 2026, 21:13 UTC

Tulu

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

DJ

Loe

6. veebr 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

DJ

Loe

6. veebr 2026, 20:34 UTC

Tulu

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

DJ

Loe

6. veebr 2026, 20:27 UTC

Tulu

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

DJ

Loe

6. veebr 2026, 20:24 UTC

Market Talk

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

DJ

Loe

6. veebr 2026, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

DJ

Loe

6. veebr 2026, 19:48 UTC

Tulu

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

DJ

Loe

6. veebr 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

DJ

Loe

6. veebr 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

DJ

Loe

6. veebr 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

DJ

Loe

6. veebr 2026, 19:17 UTC

Market Talk

USDA Says Farm Income to Decrease in 2026 -- Market Talk

DJ

Loe

6. veebr 2026, 18:50 UTC

Tulu

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Loe

6. veebr 2026, 18:47 UTC

Market Talk

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

DJ

Loe

6. veebr 2026, 18:34 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

DJ

Loe

6. veebr 2026, 17:58 UTC

Tulu

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

DJ

Loe

6. veebr 2026, 17:52 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

DJ

Loe

6. veebr 2026, 17:52 UTC

Market Talk
Tulu

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

DJ

Loe

6. veebr 2026, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

26.79% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR  26.79%

Kõrge 23 EUR

Madal 23 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Põhineb 1 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Weak Bearish Evidence

Bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bearish Evidence

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.

Muud aktsiad sektorist

SAN

Sanofi SA

80.38

↓-0.73%
help-icon Live chat